We’re excited to share that Nadia will present her astatine research at the NOAR Europe Annual Meeting during the Regular Academic Presentations & Hot Topics session (17:45–18:30) in Nantes, France👏
Her presentation, “Toward In Vivo Stability: A Comparative Study of ²¹¹At-Labeled Small Molecular Scaffolds” offers a systematic comparison of published strategies to minimize deastatination under standardized conditions. As a result, the study contributes to the development of safer and more effective radiopharmaceuticals for targeted alpha therapy.
If you’re attending, be sure to catch her talk on Tuesday, November 4th🎉
